gajananmnm
10+ Views

Regenerative Medicine Market - Future Growth, Comprehensive Analysis & Key Players

According to the new market research report “Regenerative Medicine Market by Product (Cell Therapies (Autologous, Allogenic), Stemcell Therapy, Tissue-engineering, Gene Therapy), Application (Wound Care, Musculoskeletal, Oncology, Dental, Ocular), Geography – Global Forecast to 2025″, published by MarketsandMarkets™, is projected to reach USD 17.9 billion by 2025 from USD 8.5 billion in 2020, at a CAGR of 15.9%.

Browse and in-depth TOC on “Regenerative Medicine Market”
131 – Tables
38 – Figures
165 – Pages

The Growth is largely driven by the rising prevalence of chronic diseases, genetic disorders, and cancer; rising investments in regenerative medicine research; and the growing pipeline of regenerative medicine products.

The tissue-engineered products segment accounted for the largest share of the Regenerative Medicine Market.

Based on products, segmented into tissue-engineered products, cell therapies, gene therapies, and progenitor and stem cell therapies. The tissue-engineered products segment accounted for the largest share in the market in 2019. The increasing adoption of tissue-engineered products for the treatment of chronic wounds and musculoskeletal disorders and the rising funding for the R&D of regenerative medicine products and therapies are the major factors driving the growth of this segment.

Oncology segment to register the highest growth rate during the forecast period

Based on applications, the Regenerative Medicine Market is segmented into musculoskeletal disorders, wound care, oncology, ocular disorders, dental, and other applications. In 2019, the oncology segment accounted for the highest growth rate. This can be attributed to the rising prevalence of orthopedic diseases, growing geriatric population, increasing number of stem cell research projects, growing number of clinical researches/trials, and the rich pipeline of stem cell products for the treatment of musculoskeletal disorders.

Request Research Sample Pages

North America is the largest regional market for Regenerative Medicine Market

The market is segmented into four major regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2019, North America accounted for the largest share in the market. The growth in the North American market can be attributed to rising stem cell banking, tissue engineering, and drug discovery in the region; expansion of the healthcare sector; and the high adoption of stem cell therapy and cell immunotherapies for the treatment of cancer and chronic diseases.

The major players operating in this Regenerative Medicine Market are 3M (US), Allergan plc (Ireland), Amgen, Inc. (US), Aspect Biosystems (Canada), bluebird bio (US), Kite Pharma (US), Integra LifeSciences Holdings Corporation (US), MEDIPOST Co., Ltd. (South Korea), Medtronic plc (Ireland), Anterogen Co., Ltd. (South Korea), MiMedx Group (US), Misonix (US), Novartis AG (Switzerland), Organogenesis Inc. (US), Orthocell Limited (Australia), Corestem, Inc. (South Korea), Spark Therapeutics (US), APAC Biotech (India), Shenzhen Sibiono GeneTech Co., Ltd. (China), Smith & Nephew plc (UK), Stryker Corporation (US), Takeda Pharmaceutical Company Limited (Japan), Tego Science (South Korea), Vericel Corporation (US), and Zimmer Biomet (US).
Comment
Suggested
Recent
Cards you may also be interested in
Jasa Pengiriman Bandung Takengon,Aceh Tengah
Logistik Express Jasa Pengiriman Bandung Takengon,Aceh Tengah merupakan jasa pengiriman barang dan cargo dari Bandung ke seluruh Indonesia. Logistik Express didukung oleh team operasional lapangan yang handal, customer service profesional, serta armada darat, laut, maupun udara yang memadai. Sehingga menjadikan Logistik Express sebagai jasa kirim yang aman sampai ke alamat tujuan. Bagi customer tidak perlu khawatir akan proses booking pengiriman yang rumit, karena cukup dengan menghubungi customer service maka barang kiriman anda langsung bisa di proses oleh team kami. Logistik Express juga dilengkapi dengan tracking website, sehingga pengiriman transparan dan mudah dilacak keberadaannya oleh customer. Jasa Kirim Ke Takengon,Aceh Tengah  dari LogistikExpress.ID temukan harga terbaik untuk pengiriman Express di tempat kami yang telah berpengalaman dan pastinya barang anda aman sampai di tempat tujuan. Harga Tarif  hanya Rp9.000/Kg minimal pengiriman 100Kg Tarif Termurah Di Jasa Pengiriman Online Terbaru Dan Terupdate sampai 2021 di LogistikExpress.ID . LogistikExpress.ID adalah Jasa Pengiriman yang melayani pengiriman ke Seluruh wilayah Indonesia Layanan Customer Service & Order : +62816267079 Cek Tarif pengiriman dari Bandung lainnya : Ekspedisi Bandung sinabang Ekspedisi Bandung singaraja Ekspedisi Bandung singkawang Ekspedisi Bandung singkil Ekspedisi Bandung sinjai Ekspedisi Bandung sintang Ekspedisi Bandung sipirok Ekspedisi Bandung situbondo Ekspedisi Bandung slawi Ekspedisi Bandung sleman Ekspedisi Bandung soe Ekspedisi Bandung sofifi Ekspedisi Bandung solo Ekspedisi Bandung solok Ekspedisi Bandung soppeng Ekspedisi Bandung soreang Ekspedisi Bandung sorek Ekspedisi Bandung sorong Ekspedisi Bandung sorowako
Jasa Pengiriman Bandung Bireun, Aceh (0816267079)
Logistik Express Jasa Pengiriman Bandung Bireun, Aceh merupakan jasa pengiriman barang dan cargo dari Bandung ke seluruh Indonesia. Logistik Express didukung oleh team operasional lapangan yang handal, customer service profesional, serta armada darat, laut, maupun udara yang memadai. Sehingga menjadikan Logistik Express sebagai jasa kirim yang aman sampai ke alamat tujuan. Bagi customer tidak perlu khawatir akan proses booking pengiriman yang rumit, karena cukup dengan menghubungi customer service maka barang kiriman anda langsung bisa di proses oleh team kami. Logistik Express juga dilengkapi dengan tracking website, sehingga pengiriman transparan dan mudah dilacak keberadaannya oleh customer. Jasa Kirim Ke Bireun, Aceh dari LogistikExpress.ID temukan harga terbaik untuk pengiriman Express di tempat kami yang telah berpengalaman dan pastinya barang anda aman sampai di tempat tujuan. Harga Tarif  hanya Rp9.000/Kg minimal pengiriman 100Kg Tarif Termurah Di Jasa Pengiriman Online Terbaru Dan Terupdate sampai 2021 di LogistikExpress.ID . LogistikExpress.ID adalah Jasa Pengiriman yang melayani pengiriman ke Seluruh wilayah Indonesia Layanan Customer Service & Order : +62816267079 Cek Tarif pengiriman dari Bandung lainnya : Ekspedisi Bandung bireun Ekspedisi Bandung bitung Ekspedisi Bandung blang kejeren Ekspedisi Bandung blang pidie Ekspedisi Bandung blitar Ekspedisi Bandung blora Ekspedisi Bandung bobong Ekspedisi Bandung bojonegoro Ekspedisi Bandung bombana Ekspedisi Bandung bondowoso Ekspedisi Bandung bone Ekspedisi Bandung bontang Ekspedisi Bandung boroko Ekspedisi Bandung borong Ekspedisi Bandung boyolali
Growing Support and Collaboration for Developing OTC Tests
 The growth of the OTC tests market is mainly driven by the rising prevalence of target diseases and disorders, such as diabetes and infectious diseases, both prominent ailments across the globe that require rapid and effective testing.  Growth in this market can be attributed to factors such as the increasing number of HIV-infected individuals across the globe, coupled with increasing availability and awareness about HIV OTC testing in emerging markets such as India, Brazil, and China.   The lateral flow assays segment is projected to grow at the highest rate in the market, by technology. In the past few years, the lateral flow assay POC testing market has grown significantly due to the increasing adoption of LFA testing products in-home care.   Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=78819178 The Asia Pacific is estimated to grow at the highest CAGR during the forecast period. The high growth in this regional segment is majorly attributed to the increasing patient population base and the growing prevalence of infectious diseases.  Key market players The key players operating in the global Over The Counter/OTC test industry are OraSure Technologies (US), Roche Diagnostics (Switzerland), and i-Health Lab (US). A majority of the leading players in the market focus on both organic and inorganic growth strategies such as collaborations, partnerships, acquisitions, and agreements to maintain and enhance their market shares in the OTC tests market.  Research Developments: 1. In 2019, SD Biosensor launched STANDARD GlucoNavii GDH for blood glucose monitoring. 2. In 2019, LabStyle Innovations entered into an agreement with Better Living Now (BLN) for the distribution of its Blood Glucose Monitoring System and the DarioEngage digital health platform. 3. In 2018, DarioHealth partners with Byram Healthcare to further expand insurance health coverage for consumers in the US. 4. In 2016, Sinocare acquired PTS Diagnostics, to strengthen its product portfolio and accelerate future growth in the diagnostic testing market. 
Growth in Stem Cell and Neurobiology Research are Expected in Cell Surface Markers
The largest regional market for cell surface markers is primarily driven by the increasing number of R&D activities and the growing use of cell surface markers in personalized medicine and drug discovery & development. However, the market in Asia is estimated to grow at the highest CAGR during the forecast period. The high growth of the Asian market can be attributed to the increasing number of life sciences research activities and government initiatives to boost the biotechnology and pharmaceutical industries in several Asian countries.  Clinical Applications Segment is Expected to Grow at the Highest CAGR During the Forecast Period Based on application, the cell surface markers market is segmented into research applications and clinical applications. The clinical applications segment is expected to witness higher growth during the forecast period primarily due to the rising prevalence of cancer and the increasing adoption of cell surface markers in cancer treatment. Hospitals & Clinical Testing Laboratories use Cell Surface Markers for the Diagnosis of Various Diseases On the basis of end-user, the cell surface markers market is segmented into academic & research institutes, hospitals & clinical testing laboratories, and pharmaceutical & biotechnology companies. The hospitals & clinical testing laboratories segment is expected to register the highest CAGR during the forecast period. The increasing incidence of chronic diseases such as cancer and HIV is expected to boost the demand for cell surface markers in hospitals & clinical testing laboratories in the coming years. North America is expected to be the largest regional market for cell surface markers in 2018 The global cell surface markers market is segmented into four major regions, namely, North America, Europe, Asia, and the Rest of the World. In 2018, North America is expected to account for the largest share of the market. The large share of the North American market is attributed to factors such as the increasing number of R&D activities and the growing use of cell surface markers in personalized medicine and drug discovery & development.   Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=216278622 Key Market Players The cell surface markers market is highly fragmented in nature, with several big as well as emerging players. Prominent players in this market include Thermo Fisher Scientific (US), QIAGEN N.V. (Netherlands), Becton, Dickinson and Company (US), F. Hoffman-La Roche (Switzerland), Bio-Rad Laboratories (US), Danaher Corporation (US), Abcam (UK), GenScript (China), BioLegend (US), Cell Signaling Technology (US), Merck KGaA (Germany), and Bio-Techne (US). Abcam is one of the prominent players operating in the cell surface markers market. The strong position of the company in this market can be attributed to its robust product portfolio. The company has a strong geographical presence in the European and Asia Pacific markets with its manufacturing facilities in the UK, Japan, and China. The company also has significant market presence in the US and Latin America. Thermo Fisher Scientific is another leading player in the cell surface markers market. The company’s strong brand recognition and extensive product portfolio in this market are its key strengths. To maintain its leading position in the market, the company adopts organic as well as inorganic growth strategies such as acquisitions and expansions.  Research Recent Developments Analysis 1. In 2018, Thermo Fisher Scientific acquired the Advanced Bioprocessing business of Becton, Dickinson and Company. This will be integrated into the Life Sciences Solutions segment of Thermo Fisher. 2. In 2018, Abcam entered into an exclusive license agreement with Roche. Under this agreement, the product portfolio of Spring Bioscience Corporation has been licensed to Abcam for research use only (RUO) applications. 3. In 2018, QIAGEN opened its new shared service center in Manila—QIAGEN Business Services (QBS). QBS will provide services related to supply chain management, customer care, accounting, technical services, and other sales support activities to QIAGEN'S global operations.
How to purchase lab products?
Laboratories, infirmaries, seminaries, the institution of higher education, and numerous other administrations are looking for first-class laboratory products. The marketplace is big, the quantity of Laboratory Product Manufacturers is big and does not continuously know who to select. Laboratory Apparatus Kinds The quantity of laboratory apparatus produces is very big, from kilns, incubators to minor but vital gaging tools. Amongst the kinds of produces obtainable in the laboratory are incubators, shakers, vacuity rotisseries, extractors, spectrophotometers, optical microscopes, and more. In footings of charges, too, each group and class has diverse produce at diverse capacity stages, each of which has a diverse expense. Correct acquisition of laboratory products Many businesses are beholding for laboratory products and occasionally look at the value, here's where the difficulty instigates. Beforehand you look at the value, principal of all, look at precisely what you requisite, what you are beholding for. Who is the Laboratory Product Manufacturers of a similar product, what you acquire in the same creation, all these considerations are very imperative in the purchasing process. Guarantee and overhaul on the produce When you want to purchase merchandise, you need to know what provision you will obtain about the merchandise and its guarantee. The lab produces are often costly products and we want to know that there are specialized and dependable Laboratory Product Dealers from whom we are purchasing. Here are some tips to reflect on while making a purchase. 1. Classify the Foremost Characteristics and Stipulations Distinguish how much worth a portion of the assumed product is probable to enhance to your lab and how its purposes. Examine the methodological stipulations to know the quantity of material they can check and how firm they do it. Associating the description and characteristics from several produces affects your selection of diverse apparatus with auspicious specs but destined for similar work. 2. Stare for Easy-To-Use Apparatus Purchasing a lab product from Laboratory Product Dealers, such as molecular spectroscopy, will streamline your effort. The solitary motive for acquiring apparatus is to make your work calmer and wieldy. Apparatus that has many Traits frequently make your work too complex. 3. Continuously Effort within Your Financial plan Be exact on how much you will require to purchase a part of the assumed lab apparatus before you start spending. Take into deliberation the obtainability of assets and the kind of services you offer. Contingent on the magnitude of your laboratory and stage of facilities, you can always find reasonable apparatus available with Laboratory Product Dealers. 4. Gaze at the Class and Makes Investigation on desirable makes and facsimiles. You must know all the information accessible in the market about exact lab amenities to guarantee the excellence you are expected to get when you purchase them. Apparatus from Laboratory Product Manufacturers who have been in the marketplace for an elongated time inclines to be of high class and are typically obtainable in big laboratories. Though, with the developing skill, you can find new makes and replicas that are also decent. 5. Investigate On the Past Of The Apparatus The best method to find the trajectory accounts of an individual gadget is to tête-à-tête to the Laboratory Product Suppliers. Safeguard there are no recognized glitches related to the apparatus if you are forecasting on purchasing recycled tools. If conceivable, ask for upkeep records if you are purchasing unswervingly from the laboratory to safeguard the apparatus are well preserved. Defining how much cash you are likely to expend over the next ages founded on whether you purchase recycled or new apparatus will help you make the correct conclusion. The most significant thing is to ensure if Laboratory Product Manufacturers store the classes of gears that will aid you to recover the excellence of facilities obtainable in your workroom. If you want to purchase the best Laboratory Products, look for trusted Laboratory Product Suppliers on Ozahub.
Industry Trends, Growth and Analysis For Healthcare Fraud Analytics
Fraud analytics is the efficient use of data analytics and related business insights developed through statistical, quantitative, predictive, comparative, cognitive, and other emerging applied analytical models for detecting and preventing healthcare fraud. The global healthcare fraud analytics market is projected to reach USD 5.0 billion by 2026 from USD 1.5 billion in 2021, at a CAGR of 26.7% during the forecast period. Market growth can be attributed to a large number of fraudulent activities in healthcare, the increasing number of patients seeking health insurance, high returns on investment, and the rising number of pharmacy claims-related frauds. However, the dearth of skilled personnel is expected to restrain the growth of this market.  The global healthcare fraud analytics market is facing a plethora of challenges. Travel bans and quarantines, halt of indoor/outdoor activities, temporary shutdown of business operations, supply-demand fluctuations, stock market volatility, falling business assurance, and many uncertainties are somehow exerting a partial negative impact on the business dynamics.  Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=221837663 The healthcare industry has been witnessing a number of cases of fraud, done by patients, doctors, physicians, and other medical specialists. Many healthcare providers and specialists have been observed to be engaged in fraudulent activities, for the sake of profit. In the healthcare sector, fraudulent activities done by patients include the fraudulent procurement of sickness certificates, prescription fraud, and evasion of medical charges.  A couple of reasons contributing to the growth of the health insurance market include the rise in the aging population, growth in healthcare expenditure, and increased burden of diseases. In the US, the number of citizens without health insurance has significantly decreased, from 48 million in 2010 to 28.6 million in 2016. In 2017, 12.2 million people signed up for or renewed their health insurance during the 2017 open enrollment period (Source: National Center for Health Statistics).  This growth is aided by the increasing affordability of health insurance for the middle class in this region and the rising awareness regarding the benefits of health insurance. In the UAE, as per a new regulatory policy (2017), any citizen residing and working in the UAE needs to be insured medically.   Major players in this market include IBM Corporation (US), Optum, Inc. (US), Cotiviti, Inc. (US), Change Healthcare (US), Fair Isaac Corporation (US), SAS Institute Inc. (US), EXLService Holdings, Inc. (US), Wipro Limited (India), Conduent, Incorporated (US), CGI Inc. (Canada), HCL Technologies Limited (India), Qlarant, Inc. (US), DXC Technology (US), Northrop Grumman Corporation (US), LexisNexis (US), Healthcare Fraud Shield (US), Sharecare, Inc. (US), FraudLens, Inc. (US), HMS Holding Corp. (US), Codoxo (US), H20.ai (US), Pondera Solutions, Inc. (US), FRISS (The Netherlands), Multiplan (US), FraudScope (US), and OSP Labs (US).  Research Developments Analysis 1. In January 2019, LexisNexis Risk Solutions collaborated with QuadraMed to enable patient identification capabilities and reduce the number of duplicate identities & fraudulent claims. 2. In August 2018, Verscend Technologies acquired Cotiviti Holdings. This acquisition helped improve the affordability of fraud detection solutions. 3. In June 2018, SAS Institute & Prime Therapeutics LLC teamed up, enabling Prime Therapeutics to utilize SAS’s analytic capabilities to combat the opioid crisis in the US
How Impacted COVID-19 on U.S. Shale Gas in Chemical Industry ?
Impact of COVID-19 on U.S. Shale Gas in Chemical Industry INTRODUCTION Shale gas and shale oil are defined as natural gas & oil from shale formations. Shale is a type of sedimentary rock that is made up of very small clay particles and is highly porous in nature. It is formed in deep ocean water, lagoons, wetlands, and swamps where the water is still enough for extremely fine clay and silt particles to settle to the bottom. Since shale is a porous formation, it serves as both a source and a reservoir for unconventional hydrocarbons. The extraction of oil and gas from a shale formation involves mechanical stimulation. One such technique for stimulation is hydraulic fracturing or fracking. In the fracking process, cracks in and below the Earth's surface are opened and widened by injecting water, chemicals, and sand at high pressure. The combination of horizontal drilling and hydraulic fracking has made it possible to access vast quantities of shale gas that were previously uneconomical to generate. Natural gas output from shale deposits has given the United States natural gas industry a new lease on life. The demand for safe access to energy sources is growing globally. Shale oil and gas have played an important role in meeting global energy demand during the energy revolution and are expected to continue to do so for decades as society transitions to lower-carbon energy sources. The rapid growth of shale oil and gas contributes to increased supply stability and lower commodity prices. According to the United States Energy Information Administration (EIA), in the year 2011, the country’s estimated available natural gas resources totaled 2,552 trillion cubic feet (Tcf). Natural gas from shale deposits, which was once considered to be uneconomical, accounted for 827 Tcf of this resource total. In the year 2020, U.S. dry shale gas production was about 26 trillion cubic feet (Tcf), and equal to about 78% of total U.S. dry natural gas production. IMPACT OF COVID-19 ON U.S. SHALE INDUSTRY Shale oil and gas exploration have, in particular, given the US oil and gas industry new dimensions of development. It has also fueled significant investment in associated infrastructure for gathering, storing, and delivering hydrocarbons to both domestic and foreign markets. In less than a decade, the US shale industry turned the global energy landscape upside down and re-established the US as the global energy leader. The onset of a global pandemic and subsequent drop in oil prices, on the other hand, has taken the momentum out of the shale boom. Due to a sudden drop in demand, the shale industry has immediately self-corrected. Many oil and gas players succumbed to the economic shock resulted from the CoVID-19 and filed for bankruptcy. Chesapeake Energy, a shale leader and once second-largest gas producer in the United States, filed for Chapter 11 bankruptcy protection in late June. According to the United States Energy Information Administration (EIA), the crude-oil output from seven major shale formations in the United states fell by around 56,000 barrels per day (BPD) in August 2020 to just under 7.5 million BPD, which would be the lowest level in two years. The shale industry is closely looped in with the oil and gas industry. The recent downfall of the oil and gas industry during the pandemic has had a severe impact on shale output. Post pandemic, the shale industry peaked, but the industry as a whole lost money. Since 2010, the US shale industry has produced USD 300 billion in net negative free cash flows, damaged more than USD 450 billion in invested capital, and seen more than 190 bankruptcies. With the advent of the coronavirus, the future for shale producers has become even bleaker, with a new bankruptcy filing occurring every week or so in the last few months. The pandemic's effects will be felt far beyond the US shale industry. Despite accounting for less than 10% of global oil and gas output, US shale oil extraction activity accounts for 40% of global shale oil extraction activity and accounts for nearly 100% of the growth in US midstream and export-oriented refining and petrochemical sectors over the last decade. STRATEGIC INITIATIVES DURING COVID-19 · Organization of the Petroleum Exporting Countries (OPEC) agreed on a continuation of March production levels for the month of April, with the exception of Russia and Kazakhstan, which will be authorized to increase production by 130,000 and 20,000 barrels per day, respectively, at their most recent meeting · Saudi Arabia has also agreed to extend its one-million-barrel-per-day voluntary cut for the month of April. · Companies such as Chevron, Shell, Schlumberger, and others have taken initiatives to safeguard their workforce in the ongoing pandemic situation. CONCLUSION On Conclusion, the pandemic has placed the shale industry in a delicate spot as major players are forced to cut down the output. The potential energy landscape in the United States and around the world is highly complex, and its drivers are interconnected. In the not-too-distant future, a wave of consolidation in the US shale industry could be triggered by the poor financial position of many firms and the weak economic outlook. The continuous demand for a ban on fracking, coupled with the effect of COVID, has cracked the shale industry severely. Although, the historic evidence indicates that the shale producers operate more economically. In comparison to 2019, producers in the Permian Basin are saving roughly 20% on good costs.
Why You Need A Niacinamide Serum? And How To Use It.
Niacinamide may not get as much attention as retinol and vitamin C, but it is a skincare powerhouse that deserves equal recognition. It is the definition of a multitasker, offering a host of distinct benefits that make it a good choice for a wide range of skin types and complexion issues. However, incorporating it into your current skincare routine might sound difficult. Is it OK to use niacinamide along with vitamin C and/or retinol? Is hyaluronic acid a viable alternative? We weigh in on everything you need to know about using niacinamide. What is niacinamide, exactly? Simply put, it's a B vitamin, one of two forms of vitamin B3, and it participates in a number of critical cellular operations in the skin. What benefits does it have for the skin? Buckle your seatbelts, because this is going to be a long list. Niacinamide is a fantastic treatment for acne-prone skin. Niacinamide reduces sebum production, which can help prevent acne and shine. The vitamin is also known for its anti-inflammatory qualities, which aid in the treatment of acne and other skin conditions such as eczema. Niacinamide helps to build the skin barrier, which is advantageous to people who have eczema or sensitive skin. It is also an efficient skin lightening agent, treating hyperpigmentation by blocking pigment transfer from pigment-producing cells known as melanocytes to skin cells on the surface where discoloration is visible. As if that wasn't enough, there's evidence that niacinamide can help to reduce wrinkling and photoaging by maintaining cell function and repairing DNA damage. To summarise, niacinamide has very few limitations. Is it OK to mix niacinamde and retinol? Yes! In fact, retinol and niacinamide are recommended together for faster effects. The soothing characteristics of niacinamide can also assist to alleviate the unpleasant side effects and irritation that usually accompany retinol's wrinkle-fighting effectiveness. Is it safe to combine with other ingredients? Yes, as a general rule, which is why it's found in many skincare products and is easy to incorporate into your present routine. Niacinamide is frequently coupled with salicylic acid, a beta-hydroxy acid typically found in acne products, due to its acne-fighting qualities. Combining niacinimadie's oil-removal properties with salicylic acid's ability to break down excess oil is an effective way to keep pores free and breakouts at bay. Niacinamide is an ideal choice for combining with alpha-hydroxy acids, which are chemical exfoliants that can cause skin irritation, due to its anti-inflammatory and skin barrier-strengthening effects. Because the AHAs exfoliate the dead skin cells that would otherwise make it impossible for the niacinamide to enter, combining them boosts the efficacy of the niacinamide. Finally, because niacinamide and hyaluronic acid can both help with dry skin, they are frequently mixed. What is the one thing that the jury is still out on? Vitamin C. Because vitamin C might inactivate niacinamide, the applications should be separated by 15 minutes. In truth, the two would have to be heated in order to interact negatively, and more and more cosmetics are combining the two in skin-brightening formulations. The bottom conclusion is that if you utilise a product that contains both vitamin C and niacinamide, it was most likely specifically designed to work together. If you're using two different products that include these chemicals, wait 15 minutes between applications or use one in the morning and the other in the evening. Should I use niacinamide? Sure, in a nutshell. One of the nicest aspects of niacinamide is not only the vast list of benefits it offers, but also how well it is tolerated, particularly by those with sensitive skin. This makes it an enticing choice for those whose skin is sensitive to more common acne or skin lightening agents like benzoyl peroxide or retinoids.
Refurbished Medical Equipment Market is Set to $21.2 billion by 2025
The growth of the global refurbished medical equipment market can be attributed to factors such as hospital budget cuts, a large inventory of used or old medical devices, rising demand for capital-intensive diagnostic imaging equipment, e-commerce platform enhancing the ease of purchase of refurbished medical equipment, growing preference for eco-friendly products, an increasing number of diagnostic centers & hospitals, and the growing opportunities in emerging economies.  However, factors such as stringent regulations on the import and use of refurbished medical devices in certain countries, lack in the standardization of policies for the use & sale of refurbished devices, increase in the influx of low-cost new medical devices, and the negative perception about the quality of refurbished medical devices are expected to restrain the market growth. Furthermore, the growth of the market is expected to be slowed temporarily due to the COVID-19 pandemic during the forecast period.  The refurbished medical equipment market is segmented into medical imaging equipment, operating room & surgical equipment, patient monitors, cardiology equipment, urology equipment, neurology equipment, intensive care equipment, endoscopy equipment, IV therapy systems, and other medical equipment.  Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=770 The rising demand for diagnostic imaging procedures, the high price of new medical imaging equipment, a growing number of target diseases, widening application of diagnostic imaging procedures, regulatory approvals in using refurbished medical equipment, low purchasing power in emerging economies, and established & government validated refurbishment processes adopted by major OEMs are factors expected to drive the growth of this market segment in the coming years.  The hospitals' segment accounted for the largest share of the market in 2019. The rising adoption of refurbished medical equipment, increasing focus of hospitals on providing affordable treatment and care, and growing emphasis on high returns on investment are some of the key factors driving the growth of this market.  The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period. This can be attributed to the large patient pool in the region, increasing privatization in the healthcare sector, huge patient population base, and high demand for refurbished medical equipment by low-budget hospitals and clinics.  Research Developments 1. In 2020, Siemens Healthineers (Germany) and Hamilton Health Sciences (Canada) have signed a 15 years contract that can be extended by another 10 years to provide comprehensive services for the latest imaging equipment at Hamilton Health Sciences hospitals in Canada. The deal size was approximately USD 192 million. 2. In 2019, US Med-Equip (US) acquired Medical Support Products (US) to increase the capability, national expansion, and provide greater product and service solutions across the US. 3. In 2019, Avante Health Solutions opened a new Charlotte facility in North Carolina, US. This will house three business divisions of the company viz., Avante Diagnostic Imaging, Avante Oncology, and Avante Ultrasound. 4. In 2018, Koninklijke Philips (Netherlands) acquired AGITO Medical (Denmark), strengthening its refurbished medical equipment portfolio of products, parts, and services. 5. In 2017, US Med-Equip  (US), and the Owner-Research group (US) signed a partnership to augment the economy and medical equipment products and services across hospitals in the US.
How COVID-19 Impacted on Wood Based Panel in Chemicals & Materials Industry ?
COVID-19 Impact on Wood Based Panel in Chemicals and Materials Industry The COVID-19 pandemic has influenced the whole planet with its major impacts on the economy and businesses across the globe. The COVID-19 spread worldwide in unprecedented ways due to its high infectious and contagious nature and lack of availability of its vaccine. As a result, the greatest medical challenge in the 21st century is yet to be faced by physicians worldwide. Though the emergence of the virus can be traced back to Asia, many European countries along with the U.S. have been struck massively by the pandemic. The virus has spread across all regions ranging from North America, Europe, Asia-Pacific, Middle East, and Africa up to South America. The COVID-19 has been declared as a pandemic by World Health Organization (WHO) due to its increased spread across the globe. After the declaration of the pandemic, various countries announced the complete lockdown such as India, China, and other Asian countries to decrease its spread. According to the situation report of 7th June 2021 by WHO stated 174 million cases of the corona have been reported globally and 3.7 million patients are dead due to the coronavirus. On a slightly positive note, a total of 157 million people have recovered and a total of 1.9 million vaccine doses have been administered as well. Due to the outbreak of COVID-19, demand for wood-based panels from various end-users such as residential & commercial buildings, schools, malls, and hotels is impacted due to the lockdown imposed by various national governments globally. Due to lockdown restriction, all manufacturing activities are put on hold due to lack of labour & raw material supply, which limits the demand for wood-based panels in the market. For all the key segments of the forest sector (wood harvest, sawmills, wood-based panels, pulp and paper, and wooden furniture), the biggest impact from COVID-19 was the disruption of cross-border trade, which sharply dropped in the first three quarters of 2020 compared to the same period of the previous year. Aftermath of COVID-19 and Government Initiative to Boost the Market After the COVID-19 pandemic, the wood-based panel market is expected to gain momentum due to the increasing demand from various end-users. Government of an economy and their policies plays an important role in revamping the global economy back to its anterior state. Currently, many policies are being formulated by governments for creating employment along with the utilization of resources for bringing production and sales in the market back to their previous glory. During the pandemic, various nations’ governments took immediately drastic steps to curb the increase in contamination with COVID-19 by restricting travel, closing international borders. While the various government has eased restrictions to allow the manufacture and export/import of the various goods. For Instance · European commission has issued a decision that allows for import duty and VAT relief for goods to combat the COVID-19 outbreak. Relief from import duties and VAT for goods to combat the COVID-19 outbreak is issued in Europe as a government measure to boost the country’s economy However, the governments of various nations are also trying to revive the economy with strategic decisions such as revival package of initiatives to support the small, medium, and large industries, including guaranteed loans, the micro to medium-sized enterprises were provided government support for workers’ wages, to cover interest payments on loans and to provide operating capital. Other benefits include deferral of payments on corporate income tax for businesses, including the elimination of interest payments on outstanding loans for up to three months. Strategic Decision for Manufactures after COVID-19 to Gain Competitive Market Share Although the COVID-19 pandemic has disrupted the global economy, various manufactures are trying to take market share in the region with their various CSR programs. Various international organizations of wood-based panels are also holding a virtual conference to look at furniture & design trend movements, the performance of global wood-based panel markets, and an update on innovative technologies in the wood-based panels. For instance: · Wood-Based Panels International (WBPI) holds a half-day virtual event on May 11, 2021, to look at how the international wood-based panels industry has adapted to the current pandemic, with a special focus on furniture trends Impact on Price COVID-19 has complicated the situation by depressing the various industry sectors' growth across the globe. The economic downturn weakens the demand in local as well as global markets. Due to the spread of the COVID-19 pandemic, the price of the raw materials increased drastically which in turn increased the price of lumber panels. Other factors that put upward pressure on lumber prices are the increasing cost of manufacturing and transportation. Various stakeholders are involved in the production chain of procuring, harvesting, transporting, and processing logs into lumber. Labour shortages during COVID-19 caused an increase in labour cost which has transferred to the price of lumber. For instance: · According to Random Lengths, the price of framing lumber rose to USD 1,494 per thousand board feet (mbf) in May 2021, a 250% increase when compared to USD 427 per mbf a year ago. Meanwhile, the price of structural panels jumped to USD 1,657 per thousand square feet (msf) from USD 414 over the same period, a 300% increase Impact on Demand The nationwide lockdowns imposed by the government of different nations. Most of the people are stuck at home, working from the home beginning in March 2020 encouraged many people to perform home repairs or upgrades such as outdoor decks or new wooden furniture. The high demand for houses, lower interest rates, investments in rental real estate, have resulted in high demand for lumber and structural panels. For instance: · To support the economy during COVID-19, the U.S. Federal Reserve decreased the federal funds rate to zero in March 2020, which encouraged people to enter the housing market. Historically low-interest rates have contributed to high housing demand which, in turn, raises lumber prices Impact on Supply Chain Due to the outbreak of COVID-19 globally, supply chain partners have experienced their challenges and may not be able to fulfil orders on time during the pandemic. This is primarily due to the restrictions on the movement of transportations across different countries as well as within the countries. Most of the industries are lacking workforce availability for production whereas some industries are not able to get the orders due to less demand in the market from the end-users. So overall this pandemic has affected very badly on most of the industries across the globe. For Instance: · As per a survey conducted by the Institute for Supply Chain Management on the European supply chain, it is found that nearly 75% of companies reported supply chain disruptions due to the corona virus-related transportation restrictions. In this way, the lack of workforce and demand for products from end-users has disrupted the supply chain network of the industries. Conclusion Pandemic has taken a toll on every aspect of life, including the global economy. With the significant downfalls in many sectors, a collaborative effort of government, industry players, and consumers can win the fight against COVID-19. It continues to inflict the world with appalling economic and social dilemmas, capable enough to leave severe backlash on the economy for the next several years. The first wave had already inflicted severe blows to the population as well as the economy. The currently experiencing second wave is expected to be more disastrous not only to the masses but also to CnM markets. The first wave of the COVID-19 has affected most North American & European countries such as the U.S., Mexico, Germany, France, Spain, and the U.K., among others. This pandemic has led to a disturbance in the demand and supply of wood-based panels from the end-users. Currently, the second wave of the COVID-19 is going on and it has again disturbed the economic development in the region. However, now governments are trying to get more and more people vaccinated so that spread of the virus can be controlled and economic disruption can also be minimized as compared to the first wave of the COVID-19. Ongoing relaxation in lockdown across the various regions such as North America & Europe is expected to help in the revival of the global market.
Jasa Pengiriman Bandung Simpang Tiga Redelong, Bener Meriah (0816267079)
Logistik Express Jasa Pengiriman Bandung Simpang Tiga Redelong, Bener Meriah merupakan jasa pengiriman barang dan cargo dari Bandung ke seluruh Indonesia. Logistik Express didukung oleh team operasional lapangan yang handal, customer service profesional, serta armada darat, laut, maupun udara yang memadai. Sehingga menjadikan Logistik Express sebagai jasa kirim yang aman sampai ke alamat tujuan. Bagi customer tidak perlu khawatir akan proses booking pengiriman yang rumit, karena cukup dengan menghubungi customer service maka barang kiriman anda langsung bisa di proses oleh team kami. Logistik Express juga dilengkapi dengan tracking website, sehingga pengiriman transparan dan mudah dilacak keberadaannya oleh customer. Jasa Kirim Ke  Simpang Tiga Redelong, Bener Meriah dari LogistikExpress.ID temukan harga terbaik untuk pengiriman Express di tempat kami yang telah berpengalaman dan pastinya barang anda aman sampai di tempat tujuan. Harga Tarif  hanya Rp12.000/Kg minimal pengiriman 100Kg Tarif Termurah Di Jasa Pengiriman Online Terbaru Dan Terupdate sampai 2021 di LogistikExpress.ID . LogistikExpress.ID adalah Jasa Pengiriman yang melayani pengiriman ke Seluruh wilayah Indonesia Layanan Customer Service & Order : +62816267079 Cek Tarif pengiriman dari Bandung lainnya : Ekspedisi Bandung simpang tiga redelong Ekspedisi Bandung sinabang Ekspedisi Bandung singaraja Ekspedisi Bandung singkawang Ekspedisi Bandung singkil Ekspedisi Bandung sinjai Ekspedisi Bandung sintang Ekspedisi Bandung sipirok Ekspedisi Bandung situbondo Ekspedisi Bandung slawi Ekspedisi Bandung sleman Ekspedisi Bandung soe Ekspedisi Bandung sofifi Ekspedisi Bandung solo Ekspedisi Bandung solok Ekspedisi Bandung soppeng Ekspedisi Bandung soreang Ekspedisi Bandung sorek Ekspedisi Bandung sorong Ekspedisi Bandung sorowako
Cell-based Assays Market Expected to Reach $22.0 billion by 2025
The growing preference for cell-based assays in drug discovery, increasing funding for cell-based research, and growth in the number of drug discovery activities are the key factors supporting the growth of the market.   The cell-based assays market is projected to reach USD 22.0 billion by 2025 from USD 14.9 billion in 2020, at a CAGR of 8.1% during the forecast period. However, the growth of the market is likely to be restrained by factors such as the high cost of instruments, restrictions on reagent use, and the lack of infrastructure for cell-based research in emerging economies.  Due to the pandemic, companies have scaled up R&D efforts to develop a vaccine and drugs against the SARS-CoV-2 virus. Vaccine-related research activities in pharmaceutical & biotechnological companies, research centers, and academic research institutes are considered essential and have been largely unaffected in operations and output.  The players operating in the market are altering their long-term and short-term growth strategies by tapping into opportunities prevalent in the research market by developing innovative products to combat the pandemic. The increased demand for research on COVID-19 has created a large scope for cell-based 45 assays in viral infection research, vaccine development, and overall drug discovery for both researchers and laboratories.  Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=119917269 Cell-based assays are employed to shorten the time and increase the throughput needed for these assays. This has significantly increased the demand for cell-based assays to provide an early indication of the toxicity characteristics of the drug candidates.  Cell-based assays are key components in the drug development process. Cell-based assays have several advantages over in vitro biochemical assays. They offer consistent tissue-specific responses in a biologically relevant microenvironment as opposed to biochemical assays.  It is also not possible to prepare or purify every target for biochemical measurement, which is a major factor limiting the applications of biochemical assays. As a result, pharmaceutical & biotechnology companies as well as CROs are replacing biochemical assays with cell-based assays for their lead identification and optimization processes in drug discovery.  The prominent players operating in the cell-based assays market are Danaher Corporation (US), Thermo Fisher Scientific (US), Merck KGaA (Germany), Becton, Dickinson and Company (US).  Research Developments Analysis 1. In 2020, Danaher Corporation (US) launched ImageXpress Micro-confocal High-content Imaging System. 2. In 2020, Thermo Fisher Scientific (US) acquired Phitonex, Inc. (US). The acquisition of spectral dye platform manufacturer Phitonex will enable Thermo Fisher to offer greater flow cytometry and imaging multiplexing capabilities in protein and cell analysis research. 3. In 2020, Charles River Laboratories entered into a multi-year drug discovery collaboration with Karuna Therapeutics, a US-based CRO, to expand its drug discovery capabilities. 4. In 2020, Danaher Corporation completed the acquisition of GE Healthcare’s biopharma business and was renamed as Cytiva. 5. In 2018, Lonza Group AG (Switzerland) established its Collaborative Innovation Center in the new Life Science Park on the outskirts of Haifa, Israel. This center focuses on the R&D projects of Lonza’s Pharma Biotech & Nutrition segment.
How To Make Use Of Basil Seeds For Health Benefits
Basil is a familiar spice and one found in many cuisines. Basil is derived from the Latin Basilicum which means "grass plant." Basil has a pungent and spicy taste that is used in a variety of cooking styles. There are variations of basil based on the regions where it is grown, but all types share the same taste and smell. Basil is also used as an added ingredient in food and medicine for a variety of ailments. Basil is used in India to treat many ailments including cardiovascular problems, respiratory infections, sinusitis and diarrhoea. It is used to reduce fever and alleviate coughs as well as to treat skin problems such as acne and rashes. Basil's anti-inflammatory properties help reduce swelling and reduce pain. Basil also helps alleviate discomfort from stomach cramps related to menstruation as well as reduce coughing and sore throats caused by bacteria. The pungent and aromatic nature of Basil seeds makes them good for digestion. Long-term consumption can benefit the digestive system. Digestive disorders can be reduced by including basil seeds in the diet. Basil Seeds in Urdu means "guard the duodenum" because it has fibres that protect the intestines from germs and other harmful elements. The seeds contain soluble and insoluble fibres that are essential for proper digestion. These fibres control blood sugar levels as well as cholesterol levels. They also contain sulphur-containing compounds that regulate blood sugar levels. The presence of sulphur-containing compounds aids in controlling blood sugar levels after the ingestion of foods. You can add basil seeds to the cooking water before you add any spices or herbs to your meals. Basil can be used both in soups and in sauces. You can soak some of the seeds into a container of water and drink this as an ingredient of your hot beverage such as tea or coffee. You can add dried, unsweetened, crushed or chopped basil seeds to salads or make a delicious herb salad. You can even sprinkle the leaves on top of cooked foods or in salads. You will find many interesting ways to use dried, unsweetened and chopped basil seeds or the whole plant to make interesting and tasty recipes. You can soak dried basil seeds or the whole plant to add flavour to soups, stews, salads and vegetable dishes. You will be able to use basil seeds or the whole plant in many different recipes because of their versatility.
How COVID-19 Impacted on Automated Cell Cultures in Healthcare Industry ?
COVID-19 Impact on Automated Cell Cultures in Healthcare Industry The economy and businesses across the world have been influenced greatly because of the COVID-19 pandemic. The COVID-19 has spread globally in unprecedented ways due to its high infectious and contagious nature and lack of vaccine. The World Health Organization (WHO) declared COVID-19 as a pandemic due to its increased spread across the globe. According to the situation report of 7th June 2021 by WHO, 174 million corona cases had been reported globally and 3.7 million patients died due to the coronavirus. On a slightly positive note, a total of 157 million people have recovered, and 1.9 million vaccine doses have been administered. Cell culture refers to removing cells from an animal or plant and their subsequent growth in a favorable artificial environment. Automated cell culture systems are instruments that mechanically carry out the steps involved in growing and maintaining a cell culture useful in any lab that works with cell biology, cell signaling, protein expression, or drug discovery. An automated cell culture system helps to grow cell cultures while saving labor time and reducing errors. Increasing demand for cell culture technology in vaccine production and wide acceptance of cell culture techniques in various applications accelerate the market growth. However, the high cost of automated cell culture systems and lack of skilled and certified professionals are expected to obstruct the market growth. COVID-19 pandemic created problems for many drug, clinical, medical equipment, and device manufacturing companies, including market players that provided automated cell culture products & services. Though, different kind of policies has been adopted by different companies across the globe for carrying forward the manufacturing processes. PRICE IMPACT COVID-19 claimed a considerable number of lives worldwide, which is a concern in countries with high patient co-payments and an appreciable number of families going into poverty when members become ill. Consequently, there is a need to review prices and availability of pharmaceutical products during the COVID-19 pandemic to provide future direction. The pandemic has impacted on utilization and prices of pertinent medicines and products but moderated by increased scrutiny. Key stakeholder groups can play a role in enhancing evidence-based approaches and reducing inappropriate purchasing in the future. For instance; • The Price of BACTEC FX-40 Automated Blood Culture System manufactured by BD is USD 10,608.08 • The price of Gibco HEPES, a reagent used in cell culture manufactured by Thermo Fisher Scientific, is USD 30.90 Product cost is the major setback for the market as it is expected to decrease the demand due to high costs. As the instruments and consumables related products such as cell counters, reagents, and buffers have high prices, the cost of automated cell cultures can impact the market. IMPACT ON DEMAND Today, most biotechnology products are primarily dependent on the mass culturing of cell lines. Cell cultures have found applications in diverse areas and serve as a model system for numerous research efforts. An increase in funding from the government for cell-based research is significantly triggering the growth of the market. In addition, cell culture techniques are widely used as an alternative to current egg-based strategies for developing cell-based vaccines. Thus, cell culture technology has been widely used in developing U.S. -licensed vaccines such as vaccines against rubella, smallpox, chickenpox, hepatitis, rotavirus, and polio. For instance, • Over the last month and a half, the Centre for Cellular and Molecular Biology has established stable cultures of COVID-19 causing coronavirus. The lab's ability to culture the virus enables CCMB to develop vaccines and test potential drugs to fight COVID-19. As observed, because of the current COVID-19 situation, the demand for automated cell culture services gradually increased due to the wide acceptance of cell culture techniques in various applications and growth in the biotechnology sector. This shows that various initiatives taken by organizations and market players are helping to tackle this COVID-19 situation as products are made available, and the situation is likely to get better in the future. IMPACT ON SUPPLY CHAIN Lockdown policies in different countries have resulted in the closing of product providers, decreasing walk-in customers to prevent the spread of the disease. This led to a significant delay in the supply of the product. Also, during the lockdown period, the market for online delivery of products has seen a rise, which is normal considering the situation. The companies dealing in the automated cell culture worldwide have taken strategic steps to supply products to people across the world properly. The Coronavirus Disease 2019 (COVID-19) pandemic triggered unprecedented increased demand for some clinical devices, as well as significant disruptions to global medical and clinical device manufacturing and supply chain operations. The FDA is monitoring the medical and clinical product supply chain and working closely with manufacturers and other stakeholders to evaluate the risk of disruptions and prevent or reduce their impact on patients, health care providers, and the public's health at large. For instance, · On March 27th 2020, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) was signed into law. The CARES Act added Section 506J to the Federal Food, Drug, and Cosmetic Act (FD&C Act). It provided the FDA—for the first time—with new authority intended to help prevent or mitigate negative public health impacts of medical device supply chain disruptions “during, or in advance of, a public health emergency declared by the Secretary under section 319 of the Public Health Service (PHS) Act.” The FDA issued an immediately in effect guidance, Notifying CDRH of a Permanent Discontinuance or Interruption in Manufacturing of a Device Under Section 506J of the FD&C Act During the COVID-19 Public Health Emergency: Guidance for Industry and Food and Drug Administration Staff. This guidance is intended to assist manufacturers in providing the FDA timely, informative notifications about changes in the production of certain medical devices that will help the Agency prevent or mitigate shortages of such devices during the COVID-19 public health emergency. · In April 2020, according to Indian Drug Manufacturers Association (IDMA), Vice-Chairman, T Sathish, the pharma sector in the country has been hit by a shortage of workforce, packaging materials, and transport the COVID-19 lockdown. This has led to a shortage of product packaging materials and has made matters worse for the pharmaceutical companies. He urged the government to permit the supporting industry to function to ensure that the supply chain was not disrupted. This shows that even if the COVID-19 situation disrupts the supply chain of products, the initiatives taken by the government and different companies create hope for the proper supply and use of products available. STRATEGIC DECISIONS FOR MANUFACTURERS COVID-19 might have hampered the supply and use of products, but it also allows companies to improve their business by different means. As a pharmaceutical company always does, it tends to find newer and better ways to treat a disease; the same is true with automated cell culture services and products. Always bringing out better solutions in the market will increase their business efficiency. For instance, · In 2020, in the U.S., the companies with direct exposure to COVID-19 outbreak were taking several actions, including transporting available inventory to areas away from quarantine zones and near ports where it can be accessed for shipping, buying ahead to procure inventory and raw material that are in short supply in impacted areas, activating pre-approved raw material substitutions in places where the primary supplier is impacted. However, a secondary supplier is not updating customers about delays and adjusting customer allocations to optimize profits on near-term revenue or to meet contractual terms and shaping demand by offering a discount on the available inventory in cases where supply may be short for late winter-early spring fulfillment optimizing near-term revenue. This signifies that despite this COVID-19 situation, the companies make different strategic decisions that will make their business grow at least back to pre-pandemic levels. CONCLUSION Pandemic has taken a toll on every aspect of life, including the global economy. With the significant downfalls in many sectors, a collaborative effort of government, industry players, and consumers can win the fight against COVID-19. The first wave had already inflicted severe blows to the population and economy. The currently experiencing the second wave and expected the third wave is likely to be more disastrous to the masses and healthcare markets. As this pandemic situation has resulted in many restrictions in different places around the world, the market players dealing in automated cell culture services and products were still able to manage their stock. Different companies were finding out their way to deal with this pandemic situation. The government and companies around the globe are working together and have issued advice for those who are undergoing treatment during these unprecedented times during COVID-19 lockdown around the world. The supply chain was destroyed, but several steps were taken by the government and companies, which will help them get their needed output for the products. By increasing the material price, the companies can maintain their overall revenue. Thus, different companies dealing in automated cell culture services and products are finding out their ways to deal with this pandemic situation.
Significant Impact of COVID-19 on Cellular IOT in ICT Industry
COVID-19 Impact on Cellular IOT in Information and Communication Technology Industry The pandemic started with its epicenter in China in 2019 and has been continuously spreading by then to all over the world, so far 216 countries and territories have been affected with COVID-19, the U.S. being on the top with cases reaching about 4.38 million, followed by Brazil, India and then by many European countries such as Russia, Spain, Italy, and others. The COVID-19 cases reaching to the big named countries with strong dominance in the global market which has adversely affected the economy globally. The spread of the Corona virus has led to the global recession, many companies are being bound to take stringent actions of laying off their employees, small businesses are being shut, manufacturing facilities are being put on hold. There has been a disruption in the supply chain of many industries due to restrictions in logistics and the closing of manufacturing facilities. In addition, the slowdown in the economy has lowered the spending capability of individuals and people are saving money for emergencies. However, now almost in every country, the factories are started to reopen by taking some prevention such as 20% -50% employees on the field, social distancing, extreme hygiene measures, and others to support the economy. It is supporting the economy and helping to lower the recession rate at a certain level. The pandemic has boosted the growth of the cellular IoT market. In response to the COVID-19 virus, many companies are moving towards working in a more virtual environment. This has placed a focus on organizations embracing collaboration tools and practices to support the virtual workplace. Organizations around the world are supporting the BYOD model (bring your device) to enable sales professionals to better serve their customers and prospects. Moreover, government mandate of work from home (WFH) policies has driven organizations to increasingly focus on more effective ways of engaging with customers in a remote working environment. Shifted focus towards work-from-home requires reliable connectivity and thus businesses will demand connectivity for monitoring and managing assets securely which in turn increases the demand for cellular IoT. The pandemic has exposed bottlenecks and inefficiency in the supply chains due to which businesses were leveraging cellular IoT for consignment and condition tracking to reduce revenue loss and improve product flow. Moreover, the broadband infrastructure all over the world upsurged due to a massive increase in video conferencing and video content streaming due to which cellular IoT becomes a key part of the new digitization era. For instance, · In June 2020, according to Telna whitepaper titled ‘The COVID-19 Impact on Cellular IoT’, new demand for cellular IoT following the pandemic could lead to over 11 billion cellulars IoT connections in the year 2025 IMPACT ON DEMAND The pandemic has boosted the digital transformation of industries; companies are focusing more on digital technologies to interact with their clients and customers. People are also more reliant on digital sources. The healthcare market is increasing rapidly in this pandemic. Cellular IoT (Internet of Things) in healthcare provides numerous opportunities that benefit both patients and businesses. It allows integrating and combining consumer and clinical data to create smarter and more meaningful connected consumer and care solutions and thus there has been increased o demand for cellular IoT in healthcare. As industries continue to push the boundaries of wireless technologies, new opportunities are opening for service providers within cellular IoT connectivity. Moreover, it was observed that the gradual spike in demand observed was due to the shift of consumers from traditional platforms to online digital platforms. Also due to lockdown and Covid norms, digitization and automation have become mandatory for any business. Providers need cellular IoT to provide their customers excellent experience to boost sales during this pandemic period. Also, providers need cellular IoT to analyze crucial consumer data and to drive insights for providing enhanced and personal customers experience and formulate effective marketing strategies to overcome the losses. IMPACT ON SUPPLY CHAIN The supply chain was adversely affected in the initial phase of the pandemic as lockdown prevailed in many regions globally, the government had limited the workers. Companies are making their operations work according to the government regulations by making limited workers work in different shifts. Industries were facing operational and supply chain disruptions, breakdowns, and labor shortages. Most cellular IoT providers have a large backlog of orders in hand due to chip shortages because of the disruption in the supply chain. However, now there is an improvement in the supply chain as most of the facilities and travel restrictions have opened and working in most optimum capacity. The companies are doing their best to meet the increasing demand. For Instance, · In May 2021, the chip shortage has affected the shipment volumes and profit margins of cellular IoT. Also, the global semiconductor shortage due to pandemic had affected some cellular module companies LONG TERM STRATEGY ADOPTED BY MANUFACTURERS OR STEPS TAKEN As the COVID-19 crisis continues to expand, makers would possibly face challenges on varied fronts. Producing firms would be searching for immediate measures to stay their workforces safe and their businesses solvent. Makers would conjointly have to be compelled to look on the far side of their economic viability. Because the COVID-19 pandemic intensifies, makers would possibly face continued pressure on demand, production, and revenues. They’d continuously face cash-flow liquidity challenges and difficulties in managing debt obligations. The pandemic has boosted the growth of the cellular IoT market. Thus, developers and providers were focusing on strategic decisions like partnerships, acquisition, product launch, mergers, and collaborations to meet the increasing demand in the Covid outbreak. For instance, · In April 2021, Bharti Airtel launched Airtel IoT, an integrated platform that would enable enterprises to utilize the power of the Internet of Things and prepare for the emerging era of connected things. It provides with the capability to connect and manage various devices and applications · In April 2019, AT&T launched its narrowband IoT (NB-IoT) network across the U.S., to complement its LTE-M network along with high-speed cellular coverage. Some of the IoT use cases include programs such as smart meters and location tracking, as well as connected street lights and smart appliances CONCLUSION Pandemic has taken a toll on every aspect of life, including the global economy. With the significant downfalls in many sectors, a collaborative effort of government, industry players, and consumers can win the fight against COVID-19. It continues to inflict the world with appalling economic and social dilemmas, capable enough to leave severe backlash on the economy for the next several years. The first wave had already inflicted severe blows to the population as well as the economy. The currently experiencing second wave is expected to be more disastrous not only to the masses but also to ICT markets. However, COVID-19 boosted the growth of the global cellular IoT market due to factors such as an increase in IoT connections, growing support from the government toward IoT initiatives, shift toward remote working, adoption of 5G network, surging networking budgets in countries, and ongoing development in wireless networking technologies.
How COVID-19 Impacted on Waste Water Treatment in Chemicals & Materials Industry ?
COVID-19 Impact on Waste Water Treatment in Chemicals and Materials Industry Wastewater treatment involves numerous biological, and chemical process where wastewater that contains contaminants are purified after the removal of the pollutants and the effluent obtained after the purification is cycled back to nature. Although treatment of wastewater normally takes place in a wastewater treatment plant or sewage treatment plant, the capacity, as well as technical capability of the facility varies according to the origin of the wastewater. For instance, wastewater that originates from industries is treated in industrial wastewater treatment plants that are employed with advanced chemical, biological and mechanical pieces of equipment and technologies. Some of the most common classifications of wastewater treatment plants include phase separation, biological and chemical separation, polishing, among others. Since the demand for freshwater is growing exponentially day by day, water treatment or recycling has become a necessity, particularly since urbanization is gaining a stronger pace in emerging economies. As water is an important commodity for human survival and demand for the respective product is expanding. Recycling contaminated water has become of paramount importance. As a result, the global wastewater treatment market is gaining popularity and widespread acceptance across various nooks and crannies of the globe. COVID-19 IMPACT ON GLOBAL WASTEWATER TREATMENT MARKET Even though the COVID-19 pandemic disrupted many a market across the globe and inflicted the global economy with one of the toughest crises after World War II, certain markets benefited from the pandemic from moderate to an extensive scale. The global wastewater treatment market is one such market that gained an additional market push due to the pandemic. Since SARS-CoV-2 viruses are capable of being transferred through water, large-scale treatment of water across cities, municipalities have become extremely important to curtail the spread of the virus. Similarly, the need for proper and advanced wastewater treatment in hospitals has become a major priority for governments as well authorities to contain the secondary spread of the virus. As a result, decentralized wastewater treatment plants with multiple disinfection barriers in quarantine centers, isolation wards, among others are gaining popularity across the post-COVID-19 world. In short, due to the growing demand for clean water for various industrial and human indispensabilities, the overall demand for water treatment has been growing exponentially over the years. Further, the spread of COVID-19 boosted the necessity for proper wastewater treatment in varied segments as the SARS-CoV-2 virus is capable of transferring through water sources. However, due to various restrictions in economic developments and investments such as supply disruptions, and emergency measures implemented by the government, the scale of development in the global wastewater treatment market is lackadaisical. AFTERMATH OF COVID-19 AND GOVERNMENT INITIATIVE TO BOOST THE MARKET To minimize the damage caused by the pandemic COVID-19 across the globe, various governments are implementing various measures. However, several such initiatives are boosting the demand as well as sales of the global wastewater treatment market. For instance, · After a considerable scientific exploration into the pandemic and the SARS-CoV-2 virus responsible for the pandemic, the presence of SARS-CoV-2 in sewage treatment plants was confirmed. As a result, the executive secretary of Basel, Rotterdam and Stockholm Convention (BRS) argued for the importance of wastewater management, particularly from the medical, household, among others, and named it as an essential public service to ensure minimal impacts on human and environment in the battle with COVID-19. Such governmental safety measures could spread awareness regarding wastewater treatment and could boost the pace associated with the growth of the global wastewater treatment market. Nonetheless, the pace of growth is still significantly primitive due to various socio-economic limitations associated with various parts of the world. STRATEGIC DECISIONS FOR MANUFACTURERS AFTER COVID-19 TO GAIN COMPETITIVE MARKET SHARE Manufacturers in the global wastewater treatment market experienced several adversities due to obstructions in the production facilities. Manufacturers have taken many strategic decisions such as collaboration and partnerships for the development of efficient technologies and for increasing production rate to meet the market demand once it returns to normal. Utilizing e-commerce and the establishment of local supply chains are also some of the new strategies used by various manufacturers to counter the effects of COVID-19. Moreover, several industries have enhanced information transparency among each other and are working together to help each other to overcome the financial constraints experienced and to increase cash flow into the business. PRICE IMPACT The price of water treatment equipment and accessories is expected to fluctuate due to an expected disturbance caused by the outbreak of coronavirus disease (COVID-19). Such market fluctuations have prompted manufacturers to find new contract manufacturers and suppliers to shift production operations along with new contracts for the supply of raw materials. Due to an increase in production cost and reduction in profit margins due to the shortage in raw materials, components, and difficulties in the commercialization of products, many a manufacturer is increasing prices of their products. For instance, · In June 2021, Ecolab Inc., a global leader in water, hygiene, and infection prevention solutions and services, has announced that a pricing hike of 9% and 15% will be introduced to the company’s industrial segment products effective immediately or as contracts permit due to an escalation of energy and raw material costs, limited availability of raw materials and rising transportation, packaging, utility and personnel costs IMPACT ON DEMAND COVID-19 has induced a multi-layered crisis comprising domestic price fluctuations, the overall decline of external demand, along the collapse of prices that have an impact on supply and demand for goods. The impact of this could be contemplated across the globe irrespective of the market. The COVID-19 pandemic has affected every aspect and sector as COVID-19 is an emerging, rapidly evolving situation across the world. However, several manufacturers in the global water treatment market have been utilizing this opportunity to launch new products and to address the demand created by the global discovery that the SARS-COV-2 virus is capable of transiting through wastewater. For Instance, · Suez Group introduced monitors the presence of SARS-CoV-2 in wastewater networks, capable of detecting the British variant, among others. This system manufactured by the Suez Group is currently being used in around 100 local communities in Spain, utilized by around 13 million inhabitants. Similarly, the same system is employed in100 local communities in France, with 1.8 million inhabitants. The same water treatment system is also utilized in the UK, the US, and Latin America. In short, it is appropriate to conclude that the pandemic, COVID-19 has boosted the overall demand for wastewater treatment plants and equipment across the globe. Nevertheless, the extent of the respective demand growth is relatively limited. IMPACT ON SUPPLY CHAIN The sudden outbreak of COVID-19 and its subsequent impact on restrictions on trade and movement of goods has resulted in a shutdown of vast portions of the global economy. This has in turn disrupted supply chains of the global wastewater treatment market due to the limited availability of materials and workforce. Further, due to the lockdown scenario, and restrictions in international trade, several manufacturers are also facing difficulties in clearing their old stocks. As a result, it could be conclusive to say that overall of the supply chain of the global wastewater treatment market is affected horrendously by the COVID-19 pandemic. Nevertheless, the governmental measures to unlock economies and global trade in recent months could be considered as a sign of shimmering hope for the global wastewater treatment market. CONCLUSION To recapitulate, although COVID-19 has caused a major disruption to many global economies, the pandemic has slightly boosted the demand in the global wastewater treatment market due to the fact that the SARS-CoV-2 virus, that is responsible for the pandemic could spread through savage water. The governmental regulations and initiatives regarding the urgency to curtail the pandemic also have been helping the respective market to grow. However, due to disruptions in supply chains of final products as well as raw materials, the global wastewater market is unable to tap into the demand and sales growth provided by the COVID-19 pandemic. As a result, a large-scale price increase is witnessed in products associated with the respective market. When combining and considering all these factors, it could be concluded that though, the pandemic COVID-19 has been difficult for the global wastewater market, lackadaisical progress could be witnessed for the respective market in terms of demand and sales. However, the respective market is capable of fully unleashing its potential and make excellent economic growth once the current disruptions in supply chains and manufacturing have been retracted.